Target intelligence / Profile preview

Methyltransferase 22, Kin17 lysine (METTL22)

Target
METTL22
Molecular classification
Enzyme, Protein methyltransferase, Lysine methyltransferase
01

Overview

Methyltransferase 22, Kin17 lysine (METTL22) is a non-histone protein methyltransferase that specifically trimethylates the lysine-135 residue of the DNA/RNA-binding protein Kin17 (KIN, also known as KIN or KIN17) in vitro. Kin17 is involved in crucial cellular processes such as DNA replication, DNA repair, and RNA metabolism; methylation of Kin17 by METTL22 is thought to modulate its subcellular localization and functional activity, which may impact genome maintenance and cellular stress responses. METTL22 is part of the evolutionarily conserved methyltransferase-like (METTL) protein family, classified structurally by a characteristic seven-beta-strand domain supporting S-adenosylmethionine (SAM)-dependent methyltransferase activity. The physiological and disease-related functions of METTL22 are still emerging, and while methyltransferases targeting similar substrates have been implicated in cancer and other conditions, the direct role of METTL22 is not fully established. METTL22 is broadly expressed and is active primarily in the nucleus.

Other names
Methyltransferase-like protein 22METTL22C16orf68LP8272FLJ12433MGC2654methyltransferase like 22
02

Biological functions

Protein methylationRegulation of DNA replication and repair (via substrate modification)Regulation of RNA metabolism (via substrate modification)Hematopoietic stem cell differentiation (inferred from ortholog studies)
03

Disease associations

Potential role in cancer (based on modification of proteins implicated in DNA repair and replication, but no direct strong disease association established)Other (precise involvement in specific diseases remains to be fully elucidated)

Beyond the preview

Go deeper on Methyltransferase 22, Kin17 lysine (METTL22).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Methyltransferase 22, Kin17 lysine (METTL22).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call